Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 5 registrations
- Cystadrops0.37% BASE · solution/drops · Recordati Rare
- Cystagon150MG BASE, 50MG BASE · capsule · Mylan
- Cystaran0.44% BASE · solution/drops · Leadiant Biosci INC
- Procysbi300MG BASE/PACKET, 75MG BASE/PACKET · granule, delayed release · Horizon
Canada
Health Canada · 4 registrations
At a glance
- Registers
- 2
- Registrations
- 9
- With their own page
- 9
- Companies
- 7
All medicines with Cysteamine
Human medicines from every register that match Cysteamine by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
9 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Cystagon | United States | 150MG BASE, 50MG BASE | capsule | Marketed | Mylan |
| Cystadrops | United States | 0.37% BASE | solution/drops | Marketed | Recordati Rare |
| Cystaran | United States | 0.44% BASE | solution/drops | Marketed | Leadiant Biosci INC |
| Procysbi | United States | 25MG BASE, 75MG BASE | capsule, delayed release | Marketed | Horizon |
| Procysbi | United States | 300MG BASE/PACKET, 75MG BASE/PACKET | granule, delayed release | Marketed | Horizon |
| Cystadrops | Canada | 0.37 % / W/W | Solution | Marketed | Recordati Rare Diseases Canada INC |
| Cysklar | Canada | 0.44 % W/V | Solution | Authorised | Leadiant Biosciences, INC |
| Procysbi | Canada | 25 MG | Capsule (Delayed-Release) | Marketed | Amgen Canada INC |
| Procysbi | Canada | 75 MG | Capsule (Delayed-Release) | Marketed | Amgen Canada INC |